Toggle Main Menu Toggle Search

Open Access padlockePrints

Adenosine-diphosphoribosyltransferase inhibitors can protect against or potentiate the cytotoxicity of S-phase acting drugs

Lookup NU author(s): Professor barbara Durkacz


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


We have investigated the effect of inhibitors of ADP-ribosyltransferase on the cytotoxicity of a range of S-phase acting drugs. Co-administration of 3 mM 3-aminobenzamide (3AB) potentiated the cytotoxicity of TG 2-fold, but had no effect on the cytotoxicity of HU, FdUrd or araC. Higher concentrations of benzamides (e.g. 10-20 mM 3AB) produced a G1-specific cell cycle blockade. This treatment prevented cells entering S-phase DNA synthesis and consequently protected against the cytotoxicity of the same S-phase acting drugs. Thus, using different treatment regimens with 3AB, it was possible to either potentiate or protect against the cytotoxicity of TG.

Publication metadata

Author(s): Moses K, Harris AL, Durkacz BW

Publication type: Article

Publication status: Published

Journal: Biochemical Pharmacology

Year: 1988

Volume: 37

Issue: 11

Pages: 2155-2160

ISSN (print): 0006-2952

ISSN (electronic): 1873-2968


DOI: 10.1016/0006-2952(88)90575-8

PubMed id: 3132171


Altmetrics provided by Altmetric